HER2 Gene News and Research

RSS
The HER2 (human epidermal growth factor receptor 2) gene is part of a family of genes that play roles in regulating cell growth. The protein it makes is a tyrosine kinase growth factor receptor that a number of normal tissues express and which probably has a role in normal cell function, regulating growth and proliferation.
Trop-2 new target for anti-tumour therapy in cancer

Trop-2 new target for anti-tumour therapy in cancer

Impact of food-cancer drug interactions

Impact of food-cancer drug interactions

Scientists develop largest ever series of human breasts cancers grafted into mice

Scientists develop largest ever series of human breasts cancers grafted into mice

African-Americans women more likely to present with later stage and higher grade breast cancer tumors compared to Caucasians

African-Americans women more likely to present with later stage and higher grade breast cancer tumors compared to Caucasians

Breast cancers to be more aggressive in African-American women

Breast cancers to be more aggressive in African-American women

Racial differences in severity of breast cancer presentation confirmed

Racial differences in severity of breast cancer presentation confirmed

Trastuzumab and chemo improves survival in women with operable HER-2 positive breast cancer

Trastuzumab and chemo improves survival in women with operable HER-2 positive breast cancer

Novel method of drug delivery to inhibit the growth of prostate cancer cells

Novel method of drug delivery to inhibit the growth of prostate cancer cells

Newer breast cancer drug may protect heart

Newer breast cancer drug may protect heart

Herceptin does not increase heart failure in patients long-term

Herceptin does not increase heart failure in patients long-term

Drug lapatinib shows activity against brain metastases

Drug lapatinib shows activity against brain metastases

Benefits of Herceptin are lasting

Benefits of Herceptin are lasting

Why cisplatin kills breast cancer cells when other drugs fail

Why cisplatin kills breast cancer cells when other drugs fail

New research may help identify patients most likely to benefit from cisplatin treatment

New research may help identify patients most likely to benefit from cisplatin treatment

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

New discoveries about stem cells in leukemia, breast and colon cancer

New discoveries about stem cells in leukemia, breast and colon cancer

Scientists identify protein key to breast cancer spread

Scientists identify protein key to breast cancer spread

Although breast cancer mortality has declined as a whole, declines are greatest for women under 70

Although breast cancer mortality has declined as a whole, declines are greatest for women under 70

Triple negative breast cancers more common among women who are African American and Hispanic, under 40 years old

Triple negative breast cancers more common among women who are African American and Hispanic, under 40 years old

Tykerb (lapatinib) - new anti-cancer treatment approved

Tykerb (lapatinib) - new anti-cancer treatment approved